HeyGears Unveils G1X, the World's First Desktop Full-Color 3D & UV Printer

IRVINE, Calif., July 9, 2026 /PRNewswire/ -- For creators, makers, studios, and small businesses, color has remained one of the biggest barriers in digital fabrication. Multi-color FDM is limited in detail and often creates waste towers, while resin 3D printing delivers fine detail but requires manual painting for color. Full-color 3D printing has traditionally been expensive and out of reach, with UV printing and texture creation still locked in separate workflows.

The HeyGears G1X is designed to change that. As the world's first desktop full-color 3D & UV printer, G1X combines Full-Color 3D, 3D Texture, and 2D UV printing in one desktop-scale platform. From paint-free full-color models and tactile relief effects to high-resolution surface customization across hundreds of materials, G1X gives creators a faster, more flexible way to turn digital ideas into finished physical products.

Secure your VIP early bird slot today for just $50 and receive a free 300ml bottle of White UV Ink (valued at $39) with your printer!

One Machine. Three Worlds of Creation.

The HeyGears G1X combines Full-Color 3D, 3D Texture, and 2D UV printing in one desktop system.

3D Printing Mode (Prints Full-Color 3D Models & 2.9D Deep Relief)

In 3D Mode, the G1X builds three-dimensional models layer by layer using a dedicated ink set: CMYK + Double White + Water-Soluble Support + Transparent (CMYKST+W*2). This mode produces:

• Full-Color 3D Models: Seamless, paint-free models with interior and exterior color.
• Deep Relief (2.9D): A specialized application of full-color 3D printing for deep three-dimensional relief, extending your prints up to 150 mm for enhanced expression.

UV Printing Mode (2D Printing & 3D Texture Printing)

In UV mode, the G1X 8-channel ink system and up to 1440 × 2400 DPI resolution support vivid color, fine detail, raised textures, and surface customization across 400+ compatible materials. It functions as a high-speed flatbed printer capable of producing two types of creations:

• 2D Printing: Direct high-resolution printing on 400+ compatible materials (metal, acrylic, wood, leather, ceramics).
• 3D Textures: Supports up to 10 mm of 3D texture height, though a maximum of 5 mm is recommended for superior print quality and stability, allowing you to reproduce realistic surfaces like leather, wood carving, brushstrokes, and braille.

Lower Running Costs, Built for Long-Term Use

The G1X is designed to keep everyday production more cost-efficient, not just more capable. Its affordable ink system helps reduce consumable costs for frequent printing, while the Epson I3200-U1HD  (used in G1X) industrial-grade printhead delivers stable performance with reduced clogging risk and a longer service life. With fewer interruptions, lower maintenance needs, and less frequent printhead replacements, the G1X helps creators, studios, and small businesses achieve reliable output while keeping long-term operating costs under control.

Industrial-Grade Print Quality, Speed, and Color Fidelity

G1X is designed to bring industrial-grade print performance into a desktop-scale system, combining faster UV printing, precise color reproduction, and stable long-term output.

• Epson I3200 industrial-grade printhead: Supports ultra-high-frequency jetting for faster printing, stable ink ejection, and reduced clogging risk.
• Up to 3X faster UV printing: Helps creators, studios, and small businesses improve productivity for custom projects and small-batch production.
• Advanced Raster Image Processor (RIP) algorithms: Enable 10M+ colors, smoother gradients, and more accurate visual output across different printing modes.

Note: The 3X UV printing speed boost is based on internal testing compared with desktop UV printers equipped with a single F1080 (XP600) printhead.

From Idea to Print with AI and Auto Calibration

G1X combines AI-powered creation tools with intelligent hardware alignment, making the workflow from idea to final print faster and easier.

• AI-powered modeling: With HeyVerse AI and Blueprint Studio, users can generate high-fidelity models from text or images, or convert 2D visuals into 3D Texture outputs through a simplified workflow.
• Auto calibration in seconds: Line-scan imaging identifies an object's position, shape, and edges, enabling accurate design alignment and smart layout in Blueprint Studio for more efficient, consistent batch production.
• Full-stack creation workflow: With HeyVerse, Blueprint Studio, 500+ curated assets, and text/image-to-3D generation, users can turn ideas into printable models in minutes—even without 3D modeling experience.

Early Access and Deposit Reservation

The HeyGears G1X is launching soon on Kickstarter. Join our waitlist now to secure early bird pricing.

Secure your VIP early bird slot today for just $50 and receive a free 300ml bottle of White UV Ink (valued at $39) with your printer!

About HeyGears

HeyGears specializes in 3D printing and digital manufacturing, delivering precision solutions across dental, rehabilitation, and consumer applications. From medical personalization to consumer innovation, we help restore, reshape, and reimagine what's possible—making advanced manufacturing more accessible. To learn more about HeyGears products, visit store.heygears.com or contact contact@heygears.com.

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

HeyGears Unveils G1X, the World's First Desktop Full-Color 3D & UV Printer

SAN DIEGO, July 9, 2026 /PRNewswire/ -- On the eve of the highly anticipated BIO International Convention 2026, the BIOSeedin Summer Innovation Partnering Summit successfully took place in San Diego. Hosted by bioSeedin and proudly supported by strategic partners Thermo Fisher Scientific and ACROBiosystems, the summit was uniquely designed as an international roadshow and licensing matchmaking platform dedicated to showcasing China's differentiated innovative assets.

The event drew incredible global interest, attracting over 350 registrants and more than 200 on-site attendees from over 30 countries and regions. The bustling venue underscored a shared commitment to driving cross-border exchange and accelerating the global reach of Chinese therapeutic innovations.

The summit officially kicked off with an inspiring opening address by Ms. Jenny Zhao, Co-founder and CEO of bioSeedin, who set a collaborative and forward-looking tone. The day unfolded across two major sessions—one focused on early-stage strategy and innovation, the other on late-stage global ecosystems and emerging trends.

Session 1: Early-Stage Strategy & Innovation

The first session featured a panel of global pharma leaders discussing asset evaluation and licensing strategies. Key takeaways: licensing is a strategic vehicle for long-term value creation, not a mere transaction; deals often fail due to weak biology-disease links, poor biomarker strategies, or suboptimal PK/PD profiles. Crucially, MNCs now view China as a core innovation fountain, not a cost-driven market. To succeed, Chinese biotechs must provide globally transferable GCP/GLP-compliant data, English-language CMC documentation, globally-oriented trial designs, and focused, prioritized pipelines.

A second panel explored M&A versus licensing strategies. The consensus: M&A is a long-term corporate tool, not an endpoint; licensing often builds trust toward future acquisitions. Success hinges on rigorous scientific, operational, and commercial due diligence, disciplined valuations, and seamless post-merger integration—with cross-border M&A involving China expected to rise.

The session also featured roadshow presentations from Antengene, GeneScience Pharmaceutical, and Salsola Therapeutics.

Session 2: Late-Stage Global Ecosystems & Innovation Trends

This session shifted the spotlight to late-stage assets and global ecosystem trends. Panelists emphasized that science and data remain the ultimate anchors amid global complexity. Both China and AI are permanent structural forces—China now demands a dedicated strategy from every major pharma player, while AI serves as a powerful enabler across R&D, from target discovery to clinical design, though it cannot compensate for weak basic science.

The session concluded with high-impact asset presentations from HighTide Therapeutics, Constimulus Bio, CanWell Pharma, Jiangsu Chia Tai Fenghai Pharmaceutical, Amphiprotech, and VyBio.

Empowering Connections: The bioSeedin 1on1 Partnering System

A core engine of the event's success was the bioSeedin 1on1 Partnering System. Serving as a vital bridge for attendees, the system facilitated nearly 200 high-energy, face-to-face meetings on-site. Beyond the main stage presentations and panel discussions, the partnering area was humming with vibrant conversations, reflecting an unprecedented enthusiasm for precise, deep-dive collaborations.

Looking Ahead

As the summit drew to a close, attendees left re-energized and fully prepared for the bustling week ahead at the BIO International Convention. bioSeedin extends its warmest gratitude to all the speakers, partners, and attendees who made this event an outstanding success.

We look forward to reconnecting, continuing these vital conversations, and forging new partnerships when we meet again at the JPM Healthcare Conference 2027!

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

On the Eve of BIO 2026, Chinese Innovative Assets Trigger a New Wave of Global Collaborations